STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 64 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,552,000 | +2.2% | 914,062 | -0.4% | 0.45% | +1.1% |
| Q3 2018 | $4,453,000 | -61.3% | 918,132 | -52.1% | 0.45% | -69.7% |
| Q2 2018 | $11,509,000 | -32.2% | 1,918,132 | 0.0% | 1.48% | -38.3% |
| Q1 2018 | $16,975,000 | -4.5% | 1,918,132 | -21.8% | 2.40% | -36.8% |
| Q4 2017 | $17,780,000 | -13.0% | 2,452,397 | -17.2% | 3.81% | -7.8% |
| Q3 2017 | $20,442,000 | -4.7% | 2,962,645 | -1.2% | 4.13% | -23.5% |
| Q2 2017 | $21,450,000 | +50.5% | 3,000,000 | 0.0% | 5.40% | +28.9% |
| Q1 2017 | $14,250,000 | +97.9% | 3,000,000 | 0.0% | 4.19% | +76.7% |
| Q4 2016 | $7,200,000 | – | 3,000,000 | – | 2.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $12,497,000 | 13.66% |
| Ikarian Capital, LLC | 3,392,787 | $6,412,000 | 0.48% |
| NEA Management Company, LLC | 4,141,308 | $7,827,000 | 0.41% |
| Alambic Investment Management, L.P. | 61,764 | $117,000 | 0.28% |
| KNOTT DAVID M | 181,800 | $344,000 | 0.22% |
| 683 Capital Management, LLC | 917,942 | $1,736,000 | 0.10% |
| Hudson Bay Capital Management LP | 1,409,419 | $2,664,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 388,309 | $734,000 | 0.06% |
| &PARTNERS | 15,000 | $28,000 | 0.04% |
| Diversified Trust Co | 198,534 | $375,000 | 0.02% |